Dose Escalation Study of Sorafenib and Irinotecan Combination Therapy in Pediatric Patients With Solid Tumors

Clinical trial NCT01518413 · COMPLETED

Trial details

NCT number: NCT01518413
Sponsor: HMeany
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Rhabdomyosarcoma and Other Soft Tissue Sarcomas Ewing's Sarcoma Family of Tumors Osteosarcoma Neuroblastoma Brain Tumors

Start date: 2011-12-01
Primary completion: 2015-01-01
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.